Investigation of the Effects of Longvida Curcumin on Cognitive Function, Mood and Biomarkers of Health in healthy older adults

Swinburne University of Technology, Centre for Human Psychopharmacology0 个研究点目标入组 80 人开始时间: 2016年4月13日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1.Aged 50-85 years.
•2.Willing and able to provide written informed consent.
•3.Understand and willing and able to comply with all study procedures.
•4.No history of stroke, neurological conditions (e.g. Parkinson’s, epilepsy), depression, psychiatric disorders, low base line intellect, alcohol abuse past / present.
•5.Free from dementia.
•6.Fluent in written and spoken English.
•7.Must have normal or corrected vision and not colour blind.
•8.Free from medical conditions which may affect ability to participate in the study
•9.Participants taking part in the MRI sub-study must be right handed

•1.Any significant concurrent illness including any auto-immune disorder, bleeding disorders, currently impaired cardiovascular function, Type I diabetes, glaucoma, uncontrolled high blood pressure or gallstones.
•2.Any known or suspected food allergies
•3.Smokers and users of recreational drugs (except alcohol and other food grade actives).
•4.Have participated in any other study involving an investigational product in the last 4 weeks.
•5.Taking anti-coagulant drugs or anti-cholinergics or acetylcholinesterase inhibitors.
•6.Taking steroid medications.
•7.Taking vitamins or herbal supplements that are reasonably expected to influence study measures.
•8.Left-handed participants will be ineligible to take part in the MRI sub-study.

发起方

Swinburne University of Technology, Centre for Human Psychopharmacology